Syneos Health Showcases Evolved Deployment Solutions at Future Pharma in Boston
“Today’s specialty-focused, value-driven environment demands multi-dimensional solutions beyond traditional field sales to deliver better outcomes and improved ROI,” said
Deployment Solutions delivers customizable, scalable field-facing programs integrating promotional and educational subject matter experts, including reimbursement and access managers, Medical Science Liaisons (MSLs), nurse educators, sales teams, contact center specialists, medication adherence professionals and hybrid experts. Coupled with access to deep clinical therapeutic expertise, this approach maximizes brand value.
Deployment Solutions provides agile and cost-efficient solutions in the North American, European and Asian markets for launch and mature brands. To learn more about how Deployment Solutions offers the right resourcing strategy at the right time:
- Meet with Deployment Solutions executives who will be at Future Pharma 2019 providing the opening address today at
8:10 a.m., “Commercial Team of the Future: Reducing Friction in a Complex Healthcare Landscape.”
- Visit our website to read about our ability to deliver speed to market, communicate value and provide a positive patient experience.
- Read our latest perspectives on the levers of change reshaping the future of commercial teams by downloading the Syneos Health Field Force Forecast.
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include, but are not limited to: the Company’s ability to maintain or generate new business awards; the Company’s ability to increase its market share, grow its business, and execute its growth strategies; the Company’s backlog not being indicative of future revenues and its ability to realize the anticipated future revenue reflected in its backlog; the impact of adoption of the new accounting standard of recognizing revenue from customers; the Company’s ability to adequately price its contracts and not overrun cost estimates; general and international economic, political, and other risks, including currency and stock market fluctuations and the uncertain economic environment; fluctuations in the Company’s financial results; reliance on key personnel; customer or therapeutic area concentration; and the other risk factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and other
|Investor Relations Contact:
Senior Vice President, Investor Relations
+1 919 745 2745
Executive Director, External Communications
+1 202 210 5992
Source: Syneos Health, Inc.